Clavien- Dindo | n (%) |
0 | 164 (75.2) |
1 | 20 (9.2) |
2 | 18 (8.3) |
3b | 9 (4.1) |
4a | 3 (1.4) |
5 | 4 (1.8) |
Anterior Wall Sutures | Resection With Anastomosis | Together | |
---|---|---|---|
Ileostomy | 7 (7%) | 95 (93%) | 102 |
Colostomy | 69 (59%) | 47 (41%) | 116 |
Together | 76 (35%) | 142 (65%) | 218 |
N = 218 | |
---|---|
Age | 64.6 years (26 – 90) |
Sex | |
Male | 136 (62%) |
Female | 82 (38%) |
ASA score | |
1 | 60 (27%) |
2 | 102 (47%) |
3 | 26 (12%) |
4 | 1 (0.5%) |
Time to closure | 248 days (30 – 911) |
Type of closure | AWS | RWA | p |
---|---|---|---|
All complications | 16 (7.3%) | 38 (17.4%) | > 0.05 |
Severe complications | 5 (2.2%) | 11 (5%) | > 0.05 |
< 65 years | > 65 years | p | |
All complications | 23 (10.5%) | 31 (14.2%) | > 0.05 |
Severe complications | 4 (1.8%) | 12 (5.5%) | > 0.05 |
ASA 1 & 2 | ASA 3 & 4 | p | |
All complications | 38 (17.4%) | 6 (3%) | > 0.05 |
Severe complications | 13 (6%) | 3 (1.3%) | > 0.05 |
Ileostomy | Colostomy | p | |
All complications | 27 (12.4%) | 27 (12.4%) | > 0.05 |
Severe complications | 9 (4.1%) | 7 (3.2%) | > 0.05 |
<240 days | >240 days | p | |
All complications | 14 (6.4%) | 40 (18%) | |
Severe complications | 4 (1.8%) | 12 (5.5%) | > 0.05 |
Grade | Explanation |
---|---|
Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic | |
1 | and radiological interventions. Acceptable therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and |
electrolytes, and physiotherapy. This grade also includes wound infections opened at the bedside. | |
2 | Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusions, antibiotics and total parenteral nutrition are also included. |
3 | Requiring surgical, endoscopic or radiological intervention. |
a | Intervention under regional/local anesthesia. |
b | Intervention under general anesthesia. |
4 | Life-threatening complication requiring intensive care/intensive care unit management. |
a | Single organ dysfunction. |
b | Multi-organ dysfunction. |
5 | Patient demise. |